Cargando…

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

Detalles Bibliográficos
Autores principales:	Nicholson, RI, Gee, J M W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363333/ https://www.ncbi.nlm.nih.gov/pubmed/10682656 http://dx.doi.org/10.1054/bjoc.1999.0954

Ejemplares similares

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
por: Stone, Andrew, et al.
Publicado: (2015)

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
por: McClelland, R. A., et al.
Publicado: (1998)

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
por: Sharma, A. K., et al.
Publicado: (1994)

Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004)

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.
por: Johnston, S. R., et al.
Publicado: (1997)

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
por: Borley, Annabel C, et al.
Publicado: (2008)

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
por: Roberts, M. M., et al.
Publicado: (1978)

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
por: Burmi, RS, et al.
Publicado: (2006)

Oestrogenic Endocrine Disruptors in the Placenta and the Fetus
por: Tang, Zi-Run, et al.
Publicado: (2020)

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
por: Ribas, Ricardo, et al.
Publicado: (2014)

Investigating the functional role of the oestrogen receptor in LY2 endocrine resistant breast cancer cells
por: Ramkaran, Chrisen, et al.
Publicado: (2015)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Recruitment of insulin receptor substrate-1 by erbB3 impacts on IGF-IR signalling in oestrogen receptor-positive breast cancer cells
por: Knowlden, JM, et al.
Publicado: (2010)

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer
por: Ribas, Ricardo, et al.
Publicado: (2018)

New insights into acquired endocrine resistance of breast cancer
por: Fan, Ping, et al.
Publicado: (2019)

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
por: Stone, Andrew, et al.
Publicado: (2012)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors
por: Lee, Hye-Rim, et al.
Publicado: (2013)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
por: Leake, R. E., et al.
Publicado: (1981)

Immune-Endocrine Cross-Talk in Reproductive Biology and Pathology
por: Galvão, António M., et al.
Publicado: (2014)

Oestrogen-receptor status and sites of metastasis in breast cancer.
por: Campbell, F. C., et al.
Publicado: (1981)

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
por: Hiscox, S, et al.
Publicado: (2008)

Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen.
por: Stewart, A. J., et al.
Publicado: (1992)

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro
por: Jordan, Nicola J, et al.
Publicado: (2014)

Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.
por: Long, B., et al.
Publicado: (1992)

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor
por: Bensmail, A, et al.
Publicado: (2008)

Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.
por: Barker, S., et al.
Publicado: (1989)

Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling
por: Azad, AKM, et al.
Publicado: (2015)

Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells
por: de Blaquiere, GE, et al.
Publicado: (2006)

Cross-Talk in Cell Death Signaling
por: Roy, Sophie, et al.
Publicado: (2000)

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
por: Knowlden, Janice M, et al.
Publicado: (2011)

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
por: Stone, A, et al.
Publicado: (2008)

Do classical oestrogen markers predict for clinical response to endocrine therapy?
por: Miller, William R
Publicado: (2007)

Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)

Breast cancer: a comparison of response to endocrine therapy and oestrogen excretion patterns including unusual metabolites.
por: Castagnetta, L., et al.
Publicado: (1981)

Oestrogen binding and risk factors for breast cancer.
por: Ingram, D. M., et al.
Publicado: (1990)

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer
por: Dwyer, Amy R., et al.
Publicado: (2020)

Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report
por: Cotta, Oana R, et al.
Publicado: (2011)

Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
por: Henry, J. A., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_lhlqinfutbrhqtfinf1lnhvv2m